483 Wyeth BioPharma Division of Wyeth Pharmaceuticals Jan 2019

483 Wyeth BioPharma Division of Wyeth Pharmaceuticals Jan 2019

Jee Chung FDA, Sean Marcsisin FDA$119.00 - Available Now

FDA investigators audited the Wyeth BioPharma Division of Wyeth Pharmaceuticals - Andover, MA, United States facility and issued inspectional observations (via FDA 483) on 17 Jan 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Jan 2019
  • Location: Andover, United States
  • FEI: 1222181
Add To Cart